Literature DB >> 7527085

Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene.

E Beattie1, K L Denzler, J Tartaglia, M E Perkus, E Paoletti, B L Jacobs.   

Abstract

The vaccinia virus (VV) E3L gene, which encodes a potent inhibitor of the interferon (IFN)-induced, double-stranded RNA (dsRNA)-dependent protein kinase, PKR, is thought to be involved in the IFN-resistant phenotype of VV. The E3L gene products, p25 and p20, act as inhibitors of PKR, presumably by binding and sequestering activator dsRNA from the kinase. In this study we demonstrate that VV with the E3L gene specifically deleted (vP1080) was sensitive to the antiviral effects of IFN and debilitated in its ability to rescue vesicular stomatitis virus from the antiviral effects of IFN. Infection of L929 cells with E3L-minus virus led to rRNA degradation typical of activation of the 2'-5'-oligoadenylate synthetase/RNase L system, and extracts of infected cells lacked the PKR-inhibitory activity characteristic of wild-type VV. The reovirus S4 gene, which encodes a dsRNA-binding protein (sigma 3) that can also inhibit PKR activation by binding and sequestering activator dsRNA, was inserted into vP1080. The resultant virus (vP1112) was partially resistant to the antiviral effects of IFN in comparison with vP1080. Further studies demonstrated that transient expression of the reovirus sigma 3 protein rescued E3L-minus VV replication in HeLa cells. In these studies, rescue by sigma 3 mutants correlated with their ability to bind dsRNA. Finally, vP112 was also able to rescue the replication of the IFN-sensitive virus vesicular stomatitis virus in a manner similar to that of wild-type VV. Together, these results suggest that the reovirus S4 gene can replace the VV E3L gene with respect to interference with the IFN-induced antiviral activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7527085      PMCID: PMC188598     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Reovirus RNA is infectious.

Authors:  M R Roner; L A Sutphin; W K Joklik
Journal:  Virology       Date:  1990-12       Impact factor: 3.616

2.  The phosphorylation state of eucaryotic initiation factor 2 alters translational efficiency of specific mRNAs.

Authors:  R J Kaufman; M V Davies; V K Pathak; J W Hershey
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

3.  Structure and expression of the vaccinia virus gene which prevents virus-induced breakdown of RNA.

Authors:  R F Pacha; R J Meis; R C Condit
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

4.  Cloning and expression of foreign genes in vaccinia virus, using a host range selection system.

Authors:  M E Perkus; K Limbach; E Paoletti
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

5.  Inhibitory activity for the interferon-induced protein kinase is associated with the reovirus serotype 1 sigma 3 protein.

Authors:  F Imani; B L Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

6.  Vaccinia specific kinase inhibitory factor prevents translational inhibition by double-stranded RNA in rabbit reticulocyte lysate.

Authors:  G R Akkaraju; P Whitaker-Dowling; J S Youngner; R Jagus
Journal:  J Biol Chem       Date:  1989-06-15       Impact factor: 5.157

7.  Nuclear localization of a double-stranded RNA-binding protein encoded by the vaccinia virus E3L gene.

Authors:  H Yuwen; J H Cox; J W Yewdell; J R Bennink; B Moss
Journal:  Virology       Date:  1993-08       Impact factor: 3.616

8.  Site-directed mutagenic analysis of reovirus sigma 3 protein binding to dsRNA.

Authors:  K L Denzler; B L Jacobs
Journal:  Virology       Date:  1994-10       Impact factor: 3.616

9.  Vaccinia virus host range genes.

Authors:  M E Perkus; S J Goebel; S W Davis; G P Johnson; K Limbach; E K Norton; E Paoletti
Journal:  Virology       Date:  1990-11       Impact factor: 3.616

10.  Temperature-sensitive mutants in the vaccinia virus A18R gene increase double-stranded RNA synthesis as a result of aberrant viral transcription.

Authors:  C D Bayliss; R C Condit
Journal:  Virology       Date:  1993-05       Impact factor: 3.616

View more
  88 in total

Review 1.  Translational control of viral gene expression in eukaryotes.

Authors:  M Gale; S L Tan; M G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2000-06       Impact factor: 11.056

2.  Structure of the reovirus outer capsid and dsRNA-binding protein sigma3 at 1.8 A resolution.

Authors:  A M Olland; J Jané-Valbuena; L A Schiff; M L Nibert; S C Harrison
Journal:  EMBO J       Date:  2001-03-01       Impact factor: 11.598

3.  The Ebola virus VP35 protein functions as a type I IFN antagonist.

Authors:  C F Basler; X Wang; E Mühlberger; V Volchkov; J Paragas; H D Klenk; A García-Sastre; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

4.  A role for Z-DNA binding in vaccinia virus pathogenesis.

Authors:  Yang-Gyun Kim; Maneesha Muralinath; Teresa Brandt; Matthew Pearcy; Kevin Hauns; Ky Lowenhaupt; Bertram L Jacobs; Alexander Rich
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-30       Impact factor: 11.205

5.  Species specificity of protein kinase r antagonism by cytomegalovirus TRS1 genes.

Authors:  Stephanie J Child; Greg Brennan; Jacquelyn E Braggin; Adam P Geballe
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

6.  Inhibition of cellular 2'-5' oligoadenylate synthetase by the herpes simplex virus type 1 Us11 protein.

Authors:  Ricardo Sànchez; Ian Mohr
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

7.  Loss of protein kinase PKR expression in human HeLa cells complements the vaccinia virus E3L deletion mutant phenotype by restoration of viral protein synthesis.

Authors:  Ping Zhang; Bertram L Jacobs; Charles E Samuel
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

Review 8.  Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response.

Authors:  Robert H Silverman
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

9.  Mechanism of interferon action: characterization of the intermolecular autophosphorylation of PKR, the interferon-inducible, RNA-dependent protein kinase.

Authors:  D C Thomis; C E Samuel
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

10.  The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus.

Authors:  J E Strong; M C Coffey; D Tang; P Sabinin; P W Lee
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.